Overview
AEON market data
Price History
AEON price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$3.95 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.65 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.22 – $1.45 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11.9M · P/B 0.69.
Company News
AEON Biopharma Q2 EPS $(0.02) Beats $(0.12) EstimateBenzinga · Aug 12, 2026, 8:34 PM
AEON Biopharma Regains NYSE American ComplianceBenzinga · Aug 3, 2026, 8:22 PM
Bitget Launchpool adds AEON (AEON) with 1.1M in Token RewardsGlobenewswire Inc · Jul 27, 2026, 12:15 PM
8-K filing — AEON Biopharma, Inc. (AEON)SEC EDGAR · Jul 15, 2026, 8:01 PM
Why Aehr Test Systems Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 15, 2026, 8:32 AM
AEON Biopharma shares are trading lower after the company announced the pricing of its upsized $13.75 million offering.Benzinga · Jul 14, 2026, 1:13 PM
AEON Biopharma Prices Upsized $13.75M Public Offering Of 42,688,606 Shares At $0.3221/Share And And Accompanying Two-Year Milestone.Benzinga · Jul 14, 2026, 12:10 PM
Why Vision Marine Technologies Shares Are Trading Higher By Over 60%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 14, 2026, 8:56 AM
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache SocietyGlobenewswire Inc · Jun 4, 2026, 11:15 AM
AEON Biopharma Presents New Analytical And Functional Data Supporting Biosimilarity Of ABP-450 To BOTOX At 68th Annual Scientific Meeting Of AHSBenzinga · Jun 4, 2026, 11:15 AM